Inhibrx Biosciences (INBX)
Develops biologic drug candidates led by ozekibart and INBRX-106.
$101.49
vs last close−9.18 (−8.29%)
Something off on this page? Send us feedback.
Next report
Nov 13, 26
estimated · in 51 days
EPS estimate
−$2.45
Revenue estimate
$1.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$3.09−$2.80−$1.85−$2.28−$2.11−$2.15−$2.34Pending
Estimate−$2.88−$2.55−$2.92−$2.08−$2.08−$2.37−$2.28−$2.45
Surprise−7.3%−9.8%+36.6%−9.6%−1.4%+9.3%−2.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$100.0K—$1.3M————Pending
Estimate————$1.1M——$1.9M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$2.04 | — | — |
| Sep 2027 | −$2.09 | — | — |
| Jun 2027 | −$2.26 | — | — |
| Mar 2027 | −$2.37 | — | — |
| Dec 2026 | −$2.70 | — | — |
| Nov 2026 | −$2.45 | — | — |
| Aug 2026 | −$2.28 | −$2.34 | −2.6% |
| May 2026 | −$2.37 | −$2.15 | +9.3% |
| Mar 2026 | −$2.08 | −$2.11 | −1.4% |
| Nov 2025 | −$2.08 | −$2.28 | −9.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Aug 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$2.04 | — | — | $10.3M | — | — | — |
| Sep 2027 | −$2.09 | — | — | $8.1M | — | — | — |
| Jun 2027 | −$2.26 | — | — | $5.2M | — | — | — |
| Mar 2027 | −$2.37 | — | — | $1.2M | — | — | — |
| Dec 2026 | −$2.70 | — | — | $2.4M | — | — | — |
| Nov 13, 2026 | −$2.45 | — | — | $1.9M | — | — | — |
| Aug 13, 2026 | −$2.28 | −$2.34 | −2.6% | — | — | — | −8.9% |
| May 14, 2026 | −$2.37 | −$2.15 | +9.3% | — | — | — | −1.5% |
| Mar 19, 2026 | −$2.08 | −$2.11 | −1.4% | $1.1M | — | — | −5.6% |
| Nov 14, 2025 | −$2.08 | −$2.28 | −9.6% | — | — | — | +6.0% |
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 13, 2024 | |||||||
| Jun 3, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 8, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 12, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Aug 19, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 |